Click to enlarge
The price list for the 2015 Mazda 2 SkyActiv has surfaced on Facebook ahead of the B-segmenter’s launch later this month. An OTR without insurance figure of RM85,470 is stated, for both the sedan and hatchback.
Some equipment is also mentioned, including 16-inch alloys, leather seats, keyless entry and start, a seven-inch MZD Connect touch-screen with Commander Control knob and reverse camera, shift paddles, auto climate control, i-stop start/stop system, DRLs and get this – a head-up display, which even our Mazda 3 doesn’t have. Navigation is listed as a RM1,200 option.
The only safety kit listed here is traction control, although if our oto.my ad is to be believed, the Malaysian-spec Mazda 2 will come with two airbags and stability control. No mention has been made anywhere of the i-Activsense safety suite.
The oto.my ad also indicates Soul Red, Meteor Grey, Aluminium and White body colours, as well as a three-year/100,000 km warranty and three years’/60,000 km of free service.
In the new Mazda 2, a 1.5 litre SkyActiv-G petrol four-cylinder engine with direct injection and a 14.0:1 compression ratio sends 115 hp and 148 Nm of torque to the front wheels through a six-speed SkyActiv-Drive auto.
We’ve driven the 2015 Mazda 2 – read our impressions here. You can also check out our coverage of the Indonesian-market version, as well as the sedan’s world premiere at the 2014 Thai Motor Expo.
Mazda 2 Hatch at the 2014 Indonesia International Motor Show
Mazda 2 Sedan world debut at the 2014 Thai Motor Expo
Looking to sell your car? Sell it with Carro.

AI-generated Summary ✨
Comments emphasize the Mazda 2's competitive engine features and sleek design, highlighting its value despite a high price. Concerns are raised about only having 2 airbags, which some feel compromises safety. Many compare it favorably to rivals like Honda City, Vios, and Jazz, praising its specs and styling but criticizing the price and safety features. Overall, the sentiment is a mix of admiration for the car's qualities and disappointment over the safety and pricing considerations.